This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound Therapy and Manual Therapy in Digital Ischemic Ulcers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05907200
Recruitment Status : Completed
First Posted : June 18, 2023
Last Update Posted : June 22, 2023
Sponsor:
Information provided by (Responsible Party):
Prof.ssa Giulia Letizia Mauro, University of Palermo

Brief Summary:

The objective of this before-after non-randomized trial study is to evaluate the efficacy of ultrasound therapy in combination with manual therapy in the management of systemic sclerosis patients with IDU. The main questions it intends to answer are:

• Is this combination of treatments effective in these patients in terms of improvement in hand functional ability, pain relief, injury healing, and quality of life?

Participants will receive rehabilitation treatment consisting of a combination of manual therapy (McMennel joint manipulation, pumping, and connective tissue massage) and US water immersion. The researchers will compare the group of participants, called the treatment group, with a control group to see if:

• Is the combined treatment of ultrasound therapy and manual therapy more effective in these patients than manual therapy alone?


Condition or disease Intervention/treatment Phase
Systemic Sclerosis Other: combination ultrasound therapy and manual therapy Other: manual therapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 45 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Ultrasound in Combination With Manual Therapy in the Treatment of Ischemic Digital Ulcers in Systemic Sclerosis
Actual Study Start Date : April 1, 2022
Actual Primary Completion Date : November 30, 2022
Actual Study Completion Date : December 15, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Scleroderma

Arm Intervention/treatment
Experimental: Treatment Group
It received rehabilitation treatment consisting of a combination of manual therapy (McMennel joint manipulation, pumping and connective tissue massage) and US water immersion.
Other: combination ultrasound therapy and manual therapy
The proposed manual therapy lasted 90 minutes and involved a combination of three different techniques: McMennel manipulation, connective tissue massage and mobilization technique of pumping. Patients in the treatment group also received a treatment with US (I-Tech medical device certified UT2 CE0476) in combination with manual therapy. Dipping technique was applied with a frequency of 1 MHz, intensity of 1W/cm2, duty cycle of 60% and a duration of 15 minutes per session.

Placebo Comparator: Control Group
It received rehabilitation treatment consisting of manual therapy alone
Other: manual therapy
manual treatment lasting 90 minutes which involved a combination of three different techniques: McMennel manipulation, connective tissue massage and pumping mobilization technique.




Primary Outcome Measures :
  1. functional capacity [ Time Frame: after 4 weeks of treatment ]
    Duruoz's hand index. The total score ranges from 0-90 with higher scores indicating poorer hand functioning.


Secondary Outcome Measures :
  1. pain intensity [ Time Frame: after 4 weeks of treatment ]
    numerical rating scale; the total score ranges from 0 to 10, with higher scores indicating more pain.

  2. ulcer assessment [ Time Frame: after 4 weeks of treatment ]
    Pressure Sore Status Tool; The score is between 13 and 65. Higher total scores indicated more severe wound status.

  3. disease-related quality of life [ Time Frame: after 4 weeks of treatment ]
    The 36-Item Short Form Health Survey; The score ranges from 0 to 100, where higher scores indicate improved health.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • diagnosis of SSc according to the ACR and EULAR criteria
  • presence of IDU in active phase
  • naïve to rehabilitation treatment for their hands and upper limbs
  • written in-formed consent to participate in the study.

Exclusion Criteria:

  • presence of skin lesions due to other conditions (e.g., trauma);
  • pregnancy;
  • infectious diseases (e.g. HIV, HBV, HCV);
  • myositis;
  • arthritis;
  • other rheumatological diseases and immunodepression.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05907200


Locations
Layout table for location information
Italy
Functional Recovery and Rehabilitation Unit of the A.O.U.P. Paolo Giaccone
Palermo, Italy, 90127
Sponsors and Collaborators
University of Palermo
Layout table for additonal information
Responsible Party: Prof.ssa Giulia Letizia Mauro, Professor, University of Palermo
ClinicalTrials.gov Identifier: NCT05907200    
Other Study ID Numbers: MFR0022023
First Posted: June 18, 2023    Key Record Dates
Last Update Posted: June 22, 2023
Last Verified: June 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: Yes
Keywords provided by Prof.ssa Giulia Letizia Mauro, University of Palermo:
rehabilitation
skin ulcer
ultrasound therapy
disability
Additional relevant MeSH terms:
Layout table for MeSH terms
Scleroderma, Systemic
Scleroderma, Diffuse
Sclerosis
Pathologic Processes
Connective Tissue Diseases
Skin Diseases